Article Details

Regeneron bispecific approved for myeloma; Concentra to buy IGM | BioPharma Dive

Retrieved on: 2025-07-02 16:48:33

Tags for this article:

Click the tags to see associated articles and topics

Regeneron bispecific approved for myeloma; Concentra to buy IGM | BioPharma Dive. View article details on hiswai:

Excerpt

Meanwhile, IGM is the latest struggling biotech to agree to a buyout deal from Concentra. Published July 2, 2025. By BioPharma Dive staff. Post to ...

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo